Recombinant Human DAT Protein，His

Dopamine transporter (DAT) is a critical protein in the central nervous system, primarily responsible for the reuptake of dopamine, a neurotransmitter involved in regulating mood, motivation, and reward. Dysfunctional DAT activity has been implicated in various neuropsychiatric disorders, including attention deficit hyperactivity disorder (ADHD), depression, and substance use disorders. Due to its pivotal role in dopaminergic signaling, DAT has emerged as a significant target for pharmacological intervention. Researchers have been investigating DAT's structure and function to better understand its mechanisms of action and to develop novel therapeutics that can selectively modulate its activity. Recent advancements in recombinant protein technology have enabled the expression and purification of DAT in heterologous systems, allowing for detailed studies of its biophysical properties and interactions with small molecules. These studies aim to elucidate the conformational states of DAT and how they relate to its transport cycle and inhibition by various drugs. As a result, the research on DAT not only provides insight into the fundamental biology of neurotransmission but also opens avenues for developing targeted treatments for conditions linked to dopaminergic dysregulation. Understanding the intricacies of DAT's function and the consequences of its dysfunction is crucial for advancing therapeutic strategies and improving outcomes for individuals affected by related disorders.